CLMT:NSD-Calumet Specialty Products Partners (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 13.44

Change

0.00 (0.00)%

Market Cap

USD 1.07B

Volume

0.46M

Analyst Target

USD 3.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance Brands segments. The Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. Its Montana/Renewables segment focuses on processing renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. It serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-07 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

N/A

USD 215.48B
BCPC Balchem Corporation

N/A

USD 5.42B
WDFC WD-40 Company

N/A

USD 3.30B
HWKN Hawkins Inc

N/A

USD 2.78B
IOSP Innospec Inc

N/A

USD 2.27B
GEVO Gevo Inc

N/A

USD 0.31B
HDSN Hudson Technologies Inc

N/A

USD 0.31B
MNTK Montauk Renewables Inc

N/A

USD 0.27B
LWLG Lightwave Logic Inc

N/A

USD 0.12B
AMTX Aemetis Inc

N/A

USD 0.09B

ETFs Containing CLMT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -38.96% 48% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.96% 48% F 16% F
Trailing 12 Months  
Capital Gain -14.94% 71% C- 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.94% 71% C- 36% F
Trailing 5 Years  
Capital Gain 314.81% 85% B 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 314.81% 85% B 95% A
Average Annual (5 Year Horizon)  
Capital Gain 66.36% 76% C+ 91% A-
Dividend Return 66.36% 76% C+ 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 97.08% 38% F 19% F
Risk Adjusted Return 68.35% 86% B+ 88% B+
Market Capitalization 1.07B 76% C+ 73% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector